Research Task Forces as a working “culture”
Accelerating progress through team science, VHIO’s multidisciplinary teams, coordinated by our VHIO’s Scientific Area, also work together as established Task Forces that have been created based on VHIO’s strategic vision and research priorities.
These comprehensive teams are comprised of preclinical and translational researchers, clinical investigators and medical oncologists, pathologists, other MD disciplines, clinical research nurses, data curators as well as study coordinators, and project managers, among others. Each has an appointed Chair and is coordinated by an allocated project manager from the VHIO’s Scientific Area.
Illustrative of VHIO’s commitment to team science in more effectively tackling the complexity of cancer malignancies, other investigators from the Vall d’Hebron Barcelona Hospital Campus and other research institutions, actively contribute to the activities of our dedicated task forces.
Covering major cancer malignancies (colorectal, breast, among others), as well as translational research topics (onco-imaging), VHIO’s task forces regularly convene to synergize efforts, boost collaborations among groups and between specialists, and continuously revise patients and samples’ circuits and ethics toward advancing cancer science and precision medicine.
Mimicking cancer research landscape which is continuously changing, we aim to create new task forces for uncovered pathologies, as well as other transversal areas. This includes patients, caregivers, and their families to further involve patients in our research, in alignment with ongoing policies and activities of the Vall d’Hebron University Hospital.
Model based on multidisciplinary research
Meetings scheduled regularly as needed, normally once a month
- Solid interdisciplinary structure
Oncologists, pathologists, other MD disciplines, translational/ preclinical researchers, research nurses, coordinators, etc.
- Circuits and ethics
- Thematic areas
- Colorectal cancer
- Breast cancer
- Gynecological cancers
- Prostate cancer
- Melanoma cancer
- Pancreatic cancer
- Gastric and esophageal cancer
- Kidney cancer
- Neuroendocrine tumors